Priced by the number of active patients per trial - not per seat or per API call. Annual billing saves 18% versus monthly.
Single-site studies with up to 30 active patients. Ideal for Phase I dose-escalation or single-arm Phase II cohorts.
Multi-site Phase II/III trials with up to 150 active patients. Includes sponsor-level access and full EDC integration.
Pharma sponsors running portfolios of trials across multiple CROs and investigational sites.
Annual billing saves 18%. All plans include a 30-day validation pilot at no charge. Prices in USD.
We configure DoseMind for your protocol and run retrospective simulations on historical data at no charge before your first prospective patient is enrolled.
Talk to Sales